Wbh Advisory Inc Bristol Myers Squibb CO Transaction History

Wbh Advisory Inc

$964 Million
Q1 2024

A detailed history of Wbh Advisory Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wbh Advisory Inc holds 8,793 shares of BMY stock, worth $351,632. This represents 0.05% of its overall portfolio holdings.

Number of Shares

8,793

Previous 10,549 16.65%

Holding current value

$351,632

Previous $541,000 12.01%

% of portfolio

0.05%

Previous 0.06%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$47.98 - $54.4 $84,252 - $95,526	-1,756 Reduced 16.65%	8,793 $476,000
Q4 2023 Jan 09, 2024	SELL	$48.48 - $57.85 $30,445 - $36,329	-628 Reduced 5.62%	10,549 $541,000
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $13,662 - $15,276	-236 Reduced 2.07%	11,177 $648,000
Q2 2023 Jul 12, 2023	SELL	$63.71 - $70.74 $40,774 - $45,273	-640 Reduced 5.31%	11,413 $729,000
Q1 2023 Apr 20, 2023	SELL	$65.71 - $74.53 $47,245 - $53,587	-719 Reduced 5.63%	12,053 $835,000

Q3 2022 Oct 18, 2022	BUY	$0.13 - $76.84 $0 - $76	1 Added 0.01%	12,772 $908,000
Q2 2022 Jul 12, 2022	SELL	$72.62 - $79.98 $46,041 - $50,707	-634 Reduced 4.73%	12,771 $965,000
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $102,548 - $122,964	-1,668 Reduced 11.07%	13,405 $978,000
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $138,472 - $161,426	-2,582 Reduced 14.62%	15,073 $940,000
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $15,857 - $18,575	-268 Reduced 1.5%	17,655 $1.05 Million
Q2 2021 Jul 27, 2021	SELL	$61.91 - $67.42 $123,324 - $134,300	-1,992 Reduced 10.0%	17,923 $1.21 Million
Q1 2021 Apr 19, 2021	SELL	$59.34 - $66.74 $8,426 - $9,477	-142 Reduced 0.71%	19,915 $1.26 Million
Q4 2020 Jan 21, 2021	SELL	$57.74 - $65.43 $27,195 - $30,817	-471 Reduced 2.29%	20,057 $1.33 Million
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $51,859 - $57,466	-903 Reduced 4.21%	20,528 $1.24 Million
Q2 2020 Aug 05, 2020	BUY	$54.82 - $64.09 $24,175 - $28,263	441 Added 2.1%	21,431 $1.26 Million
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $32,108 - $46,661	692 Added 3.41%	20,990 $1.17 Million
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $144,136 - $188,012	2,929 Added 16.86%	20,298 $1.3 Million
Q3 2019 Oct 25, 2019	SELL	$42.77 - $50.71 $15,183 - $18,002	-355 Reduced 2.0%	17,369 $880,000
Q2 2019 Aug 02, 2019	SELL	$44.62 - $49.34 $16,732 - $18,502	-375 Reduced 2.07%	17,724 $803,000
Q1 2019 Apr 22, 2019	BUY	$45.12 - $53.8 $5,098 - $6,079	113 Added 0.63%	18,099 $863,000
Q4 2018 Jan 29, 2019	SELL	$48.76 - $63.23 $47,589 - $61,712	-976 Reduced 5.15%	17,986 $934,000
Q3 2018 Oct 29, 2018	SELL	$55.19 - $62.25 $6,015 - $6,785	-109 Reduced 0.57%	18,962 $1.18 Million
Q2 2018 Jul 31, 2018	BUY	$50.53 - $62.98 $3,334 - $4,156	66 Added 0.35%	19,071 $1.06 Million
Q1 2018 Apr 30, 2018	BUY	$59.92 - $68.98 $24,806 - $28,557	414 Added 2.23%	19,005 $1.2 Million
Q4 2017 Jan 31, 2018	SELL	$59.94 - $65.35 $2,757 - $3,006	-46 Reduced 0.25%	18,591 $1.14 Million
Q3 2017 Nov 29, 2017	BUY	$55.23 - $63.74 $1.03 Million - $1.19 Million	18,637	18,637 $1.19 Million

Others Institutions Holding BMY

# of Institutions

2,555

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wbh Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wbh Advisory Inc with notifications on news.

Account